Return to search
A study of the effect of cotreatment of taprostene (CG 4203), a novel stabilized prostacyclin analogue, with saruplase, a gene technologically produced unglycosylated single chain urokinase-type plasminogen activator (r-scuPA), in thrombolysis in vivo
No description available.
| Identifer | oai:union.ndltd.org:bl.uk/oai:ethos.bl.uk:278267 |
| Date | January 1990 |
| Creators | Groves, Robert W. |
| Publisher | University of Bath |
| Source Sets | Ethos UK |
| Detected Language | English |
| Type | Electronic Thesis or Dissertation |
Page generated in 0.002 seconds